Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder, according to investors ...
Roche's core research spans five large areas. Boris Zaïtra, who now leads corporate business development, is confident his ...
The clearance broadens use of Omvoh, which is part of a slate of new medicines Lilly is counting on to build on its success ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback